Xact Kapitalforvaltning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $29.2M | Buy |
523,396
+163,194
| +45% | +$9.1M | 0.62% | 31 |
|
|
2019
Q4 | $23.1M | Buy |
360,202
+8,988
| +3% | +$577K | 0.39% | 49 |
|
|
2019
Q3 | $17.8M | Buy |
351,214
+29,276
| +9% | +$1.48M | 0.34% | 58 |
|
|
2019
Q2 | $14.6M | Buy |
321,938
+19,304
| +6% | +$875K | 0.3% | 63 |
|
|
2019
Q1 | $14.4M | Buy |
302,634
+7,043
| +2% | +$336K | 0.33% | 57 |
|
|
2018
Q4 | $15.4M | Sell |
295,591
-11,244
| -4% | -$584K | 0.39% | 49 |
|
|
2018
Q3 | $19M | Sell |
306,835
-24,375
| -7% | -$1.51M | 0.4% | 46 |
|
|
2018
Q2 | $18.3M | Buy |
331,210
+11,384
| +4% | +$630K | 0.39% | 46 |
|
|
2018
Q1 | $20.2M | Buy |
319,826
+11,865
| +4% | +$750K | 0.46% | 38 |
|
|
2017
Q4 | $18.9M | Buy |
307,961
+19,298
| +7% | +$1.18M | 0.45% | 39 |
|
|
2017
Q3 | $18.4M | Buy |
288,663
+2,238
| +0.8% | +$143K | 0.53% | 38 |
|
|
2017
Q2 | $16M | Buy |
286,425
+9,310
| +3% | +$519K | 0.48% | 38 |
|
|
2017
Q1 | $15.1M | Buy |
277,115
+11,732
| +4% | +$638K | 0.46% | 43 |
|
|
2016
Q4 | $15.5M | Buy |
265,383
+14,099
| +6% | +$824K | 0.54% | 37 |
|
|
2016
Q3 | $13.5M | Buy |
+251,284
| New | +$13.5M | 0.48% | 43 |
|